CONMED Corporation EC8.F Stock
CONMED Corporation Price Chart
CONMED Corporation EC8.F Financial and Trading Overview
CONMED Corporation stock price | 68 EUR |
Previous Close | 124 EUR |
Open | 124 EUR |
Bid | 124 EUR x 15100 |
Ask | 125 EUR x 14800 |
Day's Range | 124 - 124 EUR |
52 Week Range | 73.5 - 124 EUR |
Volume | 2 EUR |
Avg. Volume | 0 EUR |
Market Cap | 3.89B EUR |
Beta (5Y Monthly) | 1.384859 |
PE Ratio (TTM) | N/A |
EPS (TTM) | 2.4 EUR |
Forward Dividend & Yield | 0.74 (0.61%) |
Ex-Dividend Date | June 14, 2023 |
1y Target Est | 159.2 EUR |
EC8.F Valuation Measures
Enterprise Value | 4.77B EUR |
Trailing P/E | N/A |
Forward P/E | 32.891247 |
PEG Ratio (5 yr expected) | 1.66 |
Price/Sales (ttm) | 3.540087 |
Price/Book (mrq) | 5.0361466 |
Enterprise Value/Revenue | 4.341 |
Enterprise Value/EBITDA | 32.197 |
Trading Information
CONMED Corporation Stock Price History
Beta (5Y Monthly) | 1.384859 |
52-Week Change | 46.10% |
S&P500 52-Week Change | 20.43% |
52 Week High | 124 EUR |
52 Week Low | 73.5 EUR |
50-Day Moving Average | 106.56 EUR |
200-Day Moving Average | 90.71 EUR |
EC8.F Share Statistics
Avg. Volume (3 month) | 0 EUR |
Avg. Daily Volume (10-Days) | 0 EUR |
Shares Outstanding | 30.58M |
Float | 30.19M |
Short Ratio | N/A |
% Held by Insiders | 0.58% |
% Held by Institutions | 120.32% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 0.8 |
Trailing Annual Dividend Yield | 0.64% |
5 Year Average Dividend Yield | 81.00% |
Payout Ratio | N/A |
Last Split Factor |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | March 31, 2023 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | -8.53% |
Operating Margin (ttm) | 7.24% |
Gross Margin | 54.16% |
EBITDA Margin | 13.48% |
Management Effectiveness
Return on Assets (ttm) | 2.42% |
Return on Equity (ttm) | -12.15% |
Income Statement
Revenue (ttm) | 1.1B EUR |
Revenue Per Share (ttm) | 36.25 EUR |
Quarterly Revenue Growth (yoy) | 21.89% |
Gross Profit (ttm) | 575.75M EUR |
EBITDA | 148.11M EUR |
Net Income Avi to Common (ttm) | -93738000 EUR |
Diluted EPS (ttm) | -2.89 |
Quarterly Earnings Growth (yoy) | -87.90% |
Balance Sheet
Total Cash (mrq) | 26.49M EUR |
Total Cash Per Share (mrq) | 0.87 EUR |
Total Debt (mrq) | 1.06B EUR |
Total Debt/Equity (mrq) | 141.53 EUR |
Current Ratio (mrq) | 1.902 |
Book Value Per Share (mrq) | 24.622 |
Cash Flow Statement
Operating Cash Flow (ttm) | 29.19M EUR |
Levered Free Cash Flow (ttm) | 60.66M EUR |
Profile of CONMED Corporation
Country | Germany |
State | FL |
City | Largo |
Address | 11311 Concept Boulevard |
ZIP | 33773-4908 |
Phone | 727 392 6464 |
Website | https://www.conmed.com |
Industry | Medical Devices |
Sector(s) | Healthcare |
Full Time Employees | 4100 |
CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for surgical procedures worldwide. It offers orthopedic surgery products, including TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and Agro Knotless Suture Anchors, which provide unique clinical solutions to orthopedic surgeons for the repair of soft tissue injuries, as well as supporting products that enable surgeons to perform minimally invasive sports medicine surgeries. The company markets orthopedic surgery products under the Hall, CONMED Linvatec, Concept, and Shutt brands. It also offers general surgery products, such as clinical insufflation, smoke evacuation, electrosurgical, and endomechanical products; and endoscopic technologies, including therapeutic and diagnostic products for use in gastroenterology procedures, and products for the treatment of diseases of the dilatation, hemostasis, biliary, structure management, and infection prevention and patient monitoring, including ECG and EEG electrodes, and cardiac defibrillation pads. The company markets its products directly to hospitals, surgery centers, and other healthcare institutions, as well as through medical specialty distributors. CONMED Corporation was incorporated in 1970 and is headquartered in Largo, Florida.
Q&A For CONMED Corporation Stock
What is a current EC8.F stock price?
CONMED Corporation EC8.F stock price today per share is 68 EUR.
How to purchase CONMED Corporation stock?
You can buy EC8.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for CONMED Corporation?
The stock symbol or ticker of CONMED Corporation is EC8.F.
Which industry does the CONMED Corporation company belong to?
The CONMED Corporation industry is Medical Devices.
How many shares does CONMED Corporation have in circulation?
The max supply of CONMED Corporation shares is 31.31M.
What is CONMED Corporation Price to Earnings Ratio (PE Ratio)?
CONMED Corporation PE Ratio is 28.33333200 now.
What was CONMED Corporation earnings per share over the trailing 12 months (TTM)?
CONMED Corporation EPS is 2.4 EUR over the trailing 12 months.
Which sector does the CONMED Corporation company belong to?
The CONMED Corporation sector is Healthcare.